These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 16218879)
1. Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation. Aukrust P; Yndestad A; Smith C; Sandberg WJ; Ueland T; Waehre T; Halvorsen B; Gullestad L; Damås JK Expert Opin Pharmacother; 2005 Oct; 6(13):2169-80. PubMed ID: 16218879 [TBL] [Abstract][Full Text] [Related]
2. Inflammation in coronary artery disease: potential role for immunomodulatory therapy. Aukrust P; Yndestad A; Waehre T; Gullestad L; Halvorsen B; Damås JK Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1111-24. PubMed ID: 16293001 [TBL] [Abstract][Full Text] [Related]
3. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy. Rosenson RS Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000 [TBL] [Abstract][Full Text] [Related]
4. Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, angiotensin-converting enzyme inhibitors, cyclooxygenase-2 inhibitors, and aspirin in anti-inflammatory and immunomodulatory treatment of cardiovascular diseases. Schieffer B; Drexler H Am J Cardiol; 2003 Jun; 91(12A):12H-18H. PubMed ID: 12818730 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes. Monroe VS; Kerensky RA; Rivera E; Smith KM; Pepine CJ J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):23S-30S. PubMed ID: 12644337 [TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins. Kwak BR; Mulhaupt F; Mach F Autoimmun Rev; 2003 Oct; 2(6):332-8. PubMed ID: 14550874 [TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular mechanisms of statins: an update on pleiotropic effects. Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679 [TBL] [Abstract][Full Text] [Related]
8. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? McCarey DW; Sattar N; McInnes IB Arthritis Res Ther; 2005; 7(2):55-61. PubMed ID: 15743490 [TBL] [Abstract][Full Text] [Related]
9. Toward immunomodulatory and anti-inflammatory properties of statins. Arnaud C; Braunersreuther V; Mach F Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129 [TBL] [Abstract][Full Text] [Related]
10. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes]. Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071 [TBL] [Abstract][Full Text] [Related]
11. Plaque passivation: role of statins in acute coronary syndromes. Singh S; Bahl VK Indian Heart J; 2003; 55(6):605-10. PubMed ID: 14989509 [No Abstract] [Full Text] [Related]
12. Clinical value of drugs targeting inflammation for the management of coronary artery disease. Duchatelle V; Kritikou EA; Tardif JC Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034 [TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque? Akdim F; van Leuven SI; Kastelein JJ; Stroes ES Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164 [TBL] [Abstract][Full Text] [Related]